115 related articles for article (PubMed ID: 1465038)
1. Preoperative treatment with oestradiol in women scheduled for vaginal operation for genital prolapse. A randomised, double-blind trial.
Felding C; Mikkelsen AL; Clausen HV; Loft A; Larsen LG
Maturitas; 1992 Dec; 15(3):241-9. PubMed ID: 1465038
[TBL] [Abstract][Full Text] [Related]
2. Clinical effects of preoperative oestradiol treatment before vaginal repair operation. A double-blind, randomized trial.
Mikkelsen AL; Felding C; Clausen HV
Gynecol Obstet Invest; 1995; 40(2):125-8. PubMed ID: 8575690
[TBL] [Abstract][Full Text] [Related]
3. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
[TBL] [Abstract][Full Text] [Related]
4. Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?
Bulchandani S; Toozs-Hobson P; Verghese T; Latthe P
Post Reprod Health; 2015 Dec; 21(4):141-5. PubMed ID: 26537626
[TBL] [Abstract][Full Text] [Related]
5. Vaginal administration of low-dose oestradiol--effects on the endometrium and vaginal cytology.
Mattsson LA; Cullberg G; Eriksson O; Knutsson F
Maturitas; 1989 Sep; 11(3):217-22. PubMed ID: 2593865
[TBL] [Abstract][Full Text] [Related]
6. [Treatment with low-dose vaginal estradiol in post-menopausal women. A double-blind controlled trial].
Kjaergaard B; Walter S; Knudsen A; Johansen B; Barlebo H
Ugeskr Laeger; 1990 Mar; 152(10):658-9. PubMed ID: 2181748
[TBL] [Abstract][Full Text] [Related]
7. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.
Henriksson L; Stjernquist M; Boquist L; Alander U; Selinus I
Am J Obstet Gynecol; 1994 Sep; 171(3):624-32. PubMed ID: 8092207
[TBL] [Abstract][Full Text] [Related]
8. Oxytocin improves cytological and histological profiles of vaginal atrophy in postmenopausal women.
Al-Saqi SH; Jonasson AF; Naessén T; Uvnäs-Moberg K
Post Reprod Health; 2016 Mar; 22(1):25-33. PubMed ID: 26883689
[TBL] [Abstract][Full Text] [Related]
9. Low-dose oestradiol in the treatment of urogenital oestrogen deficiency--a pharmacokinetic and pharmacodynamic study.
Nilsson K; Heimer G
Maturitas; 1992 Oct; 15(2):121-7. PubMed ID: 1470044
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy.
Ayton RA; Darling GM; Murkies AL; Farrell EA; Weisberg E; Selinus I; Fraser ID
Br J Obstet Gynaecol; 1996 Apr; 103(4):351-8. PubMed ID: 8605133
[TBL] [Abstract][Full Text] [Related]
11. Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial.
Rahn DD; Good MM; Roshanravan SM; Shi H; Schaffer JI; Singh RJ; Word RA
J Clin Endocrinol Metab; 2014 Oct; 99(10):3728-36. PubMed ID: 24947034
[TBL] [Abstract][Full Text] [Related]
12. Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2mg and 0.03mg estriol.
Griesser H; Skonietzki S; Fischer T; Fielder K; Suesskind M
Maturitas; 2012 Apr; 71(4):360-8. PubMed ID: 22285095
[TBL] [Abstract][Full Text] [Related]
13. Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy.
Smith P; Heimer G; Lindskog M; Ulmsten U
Maturitas; 1993 Mar; 16(2):145-54. PubMed ID: 8483427
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol.
Pickar JH; Amadio JM; Hill JM; Bernick BA; Mirkin S
Menopause; 2016 May; 23(5):506-10. PubMed ID: 26836245
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial of the impact of local estrogen on postoperative tissue quality after vaginal reconstructive surgery.
Karp DR; Jean-Michel M; Johnston Y; Suciu G; Aguilar VC; Davila GW
Female Pelvic Med Reconstr Surg; 2012; 18(4):211-5. PubMed ID: 22777369
[TBL] [Abstract][Full Text] [Related]
16. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms.
Lose G; Englev E
BJOG; 2000 Aug; 107(8):1029-34. PubMed ID: 10955437
[TBL] [Abstract][Full Text] [Related]
17. A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging.
Henriksson L; Stjernquist M; Boquist L; Cedergren I; Selinus I
Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):85-92. PubMed ID: 8572039
[TBL] [Abstract][Full Text] [Related]
18. Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial.
Simon JA; Archer DF; Kagan R; Bernick B; Graham S; Constantine GD; Mirkin S
Menopause; 2017 Sep; 24(9):1003-1010. PubMed ID: 28419068
[TBL] [Abstract][Full Text] [Related]
19. Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.
Al-Saqi SH; Uvnäs-Moberg K; Jonasson AF
Post Reprod Health; 2015 Sep; 21(3):88-97. PubMed ID: 25995333
[TBL] [Abstract][Full Text] [Related]
20. Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study.
Jonasson AF; Edwall L; Uvnäs-Moberg K
Menopause Int; 2011 Dec; 17(4):120-5. PubMed ID: 22120944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
